Target type: molecularfunction
Catalysis of the transfer of an acyl group to an oxygen atom on the acceptor molecule. [GOC:ai]
O-acyltransferase activity refers to the enzymatic transfer of an acyl group from an acyl donor molecule, such as an acyl-CoA or an acyl phosphate, to an acceptor molecule. This reaction typically involves the formation of an ester bond between the acyl group and a hydroxyl group on the acceptor molecule. O-acyltransferases play crucial roles in a wide range of cellular processes, including lipid metabolism, signal transduction, protein modification, and biosynthesis of secondary metabolites. The specific function of an O-acyltransferase depends on its substrate specificity, which is determined by the active site of the enzyme. Some O-acyltransferases are highly specific for a particular acceptor molecule, while others exhibit broader substrate specificity. The catalytic mechanism of O-acyltransferases typically involves a two-step process. In the first step, the acyl donor molecule binds to the active site of the enzyme. In the second step, the acyl group is transferred from the donor molecule to the acceptor molecule. This transfer reaction is often facilitated by the presence of a catalytic residue in the active site, such as a histidine or a cysteine. The activity of O-acyltransferases can be regulated by various factors, including substrate availability, pH, temperature, and the presence of cofactors or inhibitors. The dysregulation of O-acyltransferase activity has been implicated in a variety of diseases, including cancer, diabetes, and neurodegenerative disorders. Therefore, O-acyltransferases are potential targets for drug discovery and development. '
"
Protein | Definition | Taxonomy |
---|---|---|
Cytosolic phospholipase A2 | A cytosolic phospholipase A2 that is encoded in the genome of cow. [OMA:A4IFJ5, PRO:DNx] | Bos taurus (cattle) |
Protein-serine O-palmitoleoyltransferase porcupine | A protein-serine O-palmitoleoyltransferase porcupine that is encoded in the genome of mouse. [OMA:Q9JJJ7, PRO:DNx] | Mus musculus (house mouse) |
Ghrelin O-acyltransferase | A ghrelin O-acyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96T53] | Homo sapiens (human) |
Cytosolic phospholipase A2 gamma | A cytosolic phospholipase A2 gamma that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UP65] | Homo sapiens (human) |
Ghrelin O-acyltransferase | A ghrelin O-acyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96T53] | Homo sapiens (human) |
Cytosolic phospholipase A2 | A cytosolic phospholipase A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P47712] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
indomethacin | indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis. Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic; xenobiotic metabolite |
ethylmaleimide | Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies. | maleimides | anticoronaviral agent; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.1.1 (hexokinase) inhibitor |
ici 204,219 | zafirlukast: a leukotriene D4 receptor antagonist | carbamate ester; indoles; N-sulfonylcarboxamide | anti-asthmatic agent; leukotriene antagonist |
estrone | Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens. | 17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols | antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite |
2-cyclohexen-1-one | 2-cyclohexen-1-one: RN given refers to unlabeled cpd with specified locant for double bond cyclohex-2-enone : A cyclohexenone having its C=C double bond at the 2-position. cyclohexenone : The parent compound of the cyclohexenones, composed of cyclohexanone having one double bond in the ring. | cyclohexenone | |
ursolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | geroprotector; plant metabolite | |
cholest-4-en-3-one | cholest-4-en-3-one : A cholestanoid that is cholest-4-ene substituted by an oxo group at position 3. | 3-oxo-Delta(4) steroid; cholestanoid | human metabolite; plant metabolite |
taraxerol | taraxerol : A pentacyclic triterpenoid that is oleanan-3-ol lacking the methyl group at position 14, with an alpha-methyl substituent at position 13 and a double bond between positions 14 and 15. taraxerol: structure | pentacyclic triterpenoid; secondary alcohol | metabolite |
androstan-3-one | |||
Bardoxolone | cyclohexenones | ||
bardoxolone methyl | methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate: structure in first source | cyclohexenones | |
arachidonic acid | arachidonate : A long-chain fatty acid anion resulting from the removal of a proton from the carboxy group of arachidonic acid. icosa-5,8,11,14-tetraenoic acid : Any icosatetraenoic acid with the double bonds at positions 5, 8, 11 and 14. | icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid | Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite |
N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)thio]acetamide | organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound | ||
arachidonyltrifluoromethane | AACOCF3 : A fatty acid derivative that is arachidonic acid in which the OH part of the carboxy group has been replaced by a trifluoromethyl group arachidonyltrifluoromethane: structure given in first source; inhibits 85-kDa phospholipase A2 | fatty acid derivative; ketone; olefinic compound; organofluorine compound | EC 3.1.1.4 (phospholipase A2) inhibitor |
amentoflavone | biflavonoid; hydroxyflavone; ring assembly | angiogenesis inhibitor; antiviral agent; cathepsin B inhibitor; P450 inhibitor; plant metabolite | |
ochnaflavone | ochnaflavone : A biflavonoid with an ether linkage between the B-rings of the apigenin and luteolin subunits. It has been isolated from several members of the Ochnaceae plant family. ochnaflavone: from Lonicera japonica; structure given in first source | aromatic ether; biflavonoid; hydroxyflavone | anti-inflammatory agent; antiatherogenic agent; antibacterial agent; EC 3.1.1.4 (phospholipase A2) inhibitor; leukotriene antagonist; plant metabolite |
efipladib | efipladib: structure in first source | ||
1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | |||
methyl arachidonylfluorophosphonate | phosphonic ester | ||
pyrrophenone | pyrrophenone: structure in first source | ||
2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide: synthetic potential anticarcinogenic | ||
lgk974 | LGK974 : A carboxamide, the structure of which is that of acetamide substituted on carbon by a 2',3-dimethyl-2,4'-bipyridin-5-yl group and on nitrogen by a 5-(pyrazin-2-yl)pyridin-2-yl group. It is a highly potent, selective and orally bioavailable Porcupine inhibitor (a Wnt signalling inhibitor). LGK974: a potent and specific small-molecule inhibitor of Porcupine (PORCN) acyltransferase | bipyridines; pyrazines; pyridines; secondary carboxamide | Wnt signalling inhibitor |
g007-lk | G007-LK: potent and specific small-molecule tankyrase inhibitor; structure in first source |